People In Brief
Weinberg succeeds Dehecq as Sanofi chairman: The Sanofi-Aventis board appoints Serge Weinberg chairman to succeed Jean Francois Dehecq, who resigns his board duties but will serve as honorary board chairman and as president of the newly formed Sanofi Espoir Foundation, which supports implementing health and solidarity programs worldwide. In a May 17 release, Dehecq said he leaves the chairman post after record revenue year for the firm and "with confidence in the collaboration of Serge Weinberg and [CEO] Chris Viehbacher to lead Sanofi-Aventis to further successes." Sanofi, which expects to double its OTC segment's size in five years through acquisitions by 2014, made an offer for Polish consumer product firm Nepentes. The firm's consumer health care business grew 42.5 percent to $661.1 million in most recent quarter (see story p. 6)
More from Archive
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
More from Pink Sheet
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.
In an unusual move, Tracy Beth Høeg, a special assistant to FDA Commissioner Martin Makary, is leading the continued negotiations on Novavax’s delayed COVID-19 vaccine approval.
Respondents to a Senate investigation that could re-energize 340B reform efforts said hospitals offer patient assistance programs and use 340B revenue for “capital improvement projects” and “community benefit programs,” though they do not account for specific program revenue allocations.